Test Bank For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson

TEST BANK FOR PHARMACOTHERAPEUTICS FOR A
l l l l l



DVANCED PRACTICE- l



A PRACTICAL APPROACH 5TH EDITION ARCANGEL
l l l l l l



O ALL CHAPTERS INCLUDED|| LATEST AND COMPL
l l l l l l



ETE UPDATE 2025WITH VERIFIED SOLUTIONS|| GUA
l l l l l l



RANTEED A+ l

,1 |lPl al gl e


TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED PRACTI
l l l l l l


CE-
A PRACTICAL APPROACH 5TH EDITION ARCANGELO ALLCHAPTERS IN
l l l l l l l l l


CLUDED|| LATEST AND COMPLETE UPDATE 2025 WITH VERIFIED SOLU
l l l l l l l l


TIONS|| GUARANTEED A+
l l




Pharmacology for Advanced Practice Nursing (Kennesaw State University)
l l l l l l l




Chapter 01: Issues for the Practitioner in Drug Therapy
l l l l l l l l




l MULTIPLE CHOICE l




1. Nurse practitioner prescriptive authority is regulated by:
l l l l l l




A. The National Council of State Boards of Nursing
l l l l l l l




B. The U.S. Drug Enforcement Administration
l l l l




C. The State Board of Nursing for each state
l l l l l l l




D. The State Board of Pharmacy
l l l l




ANSWER- C l PTS: 1 l




2. Physician Assistant (PA) prescriptive authority is regulated by:
l l l l l l l



A. The National Council of State Boards of Nursing
l l l l l l l




B. The U.S. Drug Enforcement Administration
l l l l




C. The State Board of Nursing
l l l l



D. The State Board of Medical Examiners
l l l l l




ANSWER- D l PTS: 1 l




3. Clinical judgment in prescribing includes:
l l l l



A. Factoring in the cost to the patient of the medication prescribed
l l l l l l l l l l




B. Always prescribing the newest medication available for the disease process
l l l l l l l l l

,2 |lPl al gl e


C. Handing out drug samples to poor patients
l l l l l l




D. Prescribing all generic medications to cut costs
l l l l l l




ANSWER- A l PTS: 1 l




4. Criteria for choosing an effective drug for a disorder include:
l l l l l l l l l




A. Asking the patient what drug they think would work best for them
l l l l l l l l l l l




B. Consulting nationally recognized guidelines for disease management
l l l l l l




C. Prescribing medications that are available as samples before writing apre
l l l l l l l l l l


scription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines forpr
l l l l l l l l


escribing
ANSWER- B l PTS: 1 l




5. Nurse practitioner practice may thrive under health-care reform due to:
l l l l l l l l l



A. The demonstrated ability of nurse practitioners to control costs and improvepati
l l l l l l l l l l l


ent outcomes
l




B. The fact that nurse practitioners will be able to practice independently
l l l l l l l l l l



C. The fact that nurse practitioners will have full reimbursement under health-
l l l l l l l l l l


care reform
l l




D. The ability to shift accountability for Medicaid to the state level
l l l l l l l l l l




ANSWER- A l PTS: 1 l

, 3 |lPl al gl e




Chapter 2: Pharmacokinetic Basis of Therapeutics and PharmacodynamicMUL
l l l l l l l l




TIPLE CHOICE l




1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This iscriti
l l l l l l l l l l l


cal to prescribing because:
l l l



A. Distribution of drugs to target tissue may be affected l l l l l l l l




B. The solubility of the drug will not match the site of absorption
l l l l l l l l l l l




C. There will be less free drug available to generate an effect
l l l l l l l l l l



D. Drugs bound to albumin are readily excreted by the kidney
l l l l l l l l l




ANSWER- A l PTS: 1 l




2. Drugs that have a significant first-pass effect:
l l l l l l




A. Must be given by the enteral (oral) route only
l l l l l l l l




B. Bypass the hepatic circulation
l l l




C. Are rapidly metabolized by the liver and may have little if any desired action
l l l l l l l l l l l l l




D. Are converted by the liver to more active and fat-soluble forms
l l l l l l l l l l




ANSWER- C l PTS: 1 l




3. The route of excretion of a volatile drug will likely be:
l l l l l l l l l l